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REITH, WILLIAMS AND THOMAS (1961) have reported results using a standard-
ised technique for the 131I-triolein fat absorption test. In studying how the
presence of diseases other than those involving fat malabsorption affected the
results, it was observed that the level of blood radioactivity was below the normal
range when malignant disease was present.
This observation has now been studied in 34 cases, brief details of these being
given in Table I. Patients with tumours of the gastro-intestinal tract were
excluded from the series. The age range was 13-89 years and there were 22
males and 12 females.
METHODS
Details of the preparation and standardisation of the labelled fatty meal are
givenby Reith etal. (1961). Thyroiduptake of131Iwas blockedbythe administra-
tion ofLugol's solution on each ofthe two days preceding the test and on the day
of the test the patient fasted overnight and ingested the labelled meal at about
9 a.m., and thereafter remained fiasting until about noon, when food and fluid
was allowed to be taken normally. Venous blood samples were taken at 2, 3,
4 and 6 hours after ingestion of the meal and faeces were collected 24 hourly
until the faecal radioactivity had fallen approximately to background level.
The results of the tests were referred to those from a group of 8 normal sub-
jects. The mean value of blood radioactivity at 2, 4 and 6 hours after ingestion
of the meal was compared with the corresponding mean value in the whole malig-
nant series, in the connective tissue tumour series, and in the carcinoma series,
by applying Student's t test. A similar statistical comparison was made in a
group of patients on whom the study was made both before treatment, andafter
tumour regression and clinical improvement had followed treatment.
RESULTS
The radioactivity contained in the total circulating blood in a group of normal
subjects is shown in Fig. 1.
The broken line in Fig. 1 represents the mean circulating radioactivity and the
shaded area one standard deviation on either side of the mean. Intercomparison
between patients is difficult because of the irregular shape of the curves, so in
each case the area enclosed by the curve, the abscissa, and the 6-hour ordinate
was calculated and expressed as fraction of the similar area bounded by the curve
of the mean normal plus one standard deviation (upper limit of the shaded area).
This fraction was called the "relative manipulation curve area" (R.M.C.A.).
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TABLE I.-Experimental Data of the Malignant Series and of the Control Series
Activity of whole circulating
blood as % of meal
Patients Sex Age 2 hours 4 hours 6 hours R.M.C.A.
Group of
normal8
B . . M. . 18.2 14.2 11.8 . 83.4
C . . . . 7 8 20.0 7 4 . 69.0
D . F. . . 24.7 15.6 15.4 . 104.2
E . M. . 14.0 17.6 15.5 . 848
I . , . . 18.7 14.7 13.9 . 87 2
N . F. . 13*4 13*5 10.6 . 700
BF ... 13*9 16.0 12.7 . 81*5
2BF . .... 10.7 16.0 12.1 . 74 6
Malignant
neopla8m
BY . F . 44 . 1-3 6-4 7 3 . 24.5
CH . . 49 . 9.1 9-5 8*4 . 48.6
CI . . 69 8 6 14.0 9 3 . 65.8
CO . M . 19 . 6.4 7.4 7.7 . 37.2
AC . 9. 13 . 0.7 13.9 9.0 . 41.6
AE .9.. 31 . 7.8 9.1 7-3 . 45.4
AN 9. 23 . 7 0 18*3 9*5 . 65.3
AI . . . 59 . 4 7 9.2 8 6 . 39.7
BA . . F. 63 . 4.2 9.2 9.4 . 39.2
AF . . M. . 38 . 7 7 12-5 6.2 . 50.6
CT .. 74 . 9.0 15.2 11.7 65.8
CU . . 62 . 5.1 18.0 14.3 . 62.0
CX . . 54 . 6.4 7*8 13.7 . 46.0
CY . . . 74 . 11.7 11.9 18.1 . 67 4
BW . F 78 . 9.5 10-5 10.1 . 54.5
BX . . ,, . 66 . 4.6 6 3 5.8 . 29.8
CA .. 74 . 8.1 8 6 8 2 . 45.3
BZ . . . 86 . 5.5 21.5 16.5 . 77 2
CC . . M. . 70 . 6 4 13.8 8.4 . 53 0
CD . . F. 67 8.1 17-2 12.1 . 674
CF .. 57 . 7 0 13-1 10.0 . 53.7
CG . . . 81 . 7.7 9 7 82 . 46-6
CK . M. 53 . 71 8-9 8 6 . 43.9
CL . . F. . 67 . 12-0 13-4 10-5 . 66-0
CM . M. 69 . 5.4 8-1 10.2 . 40 3
AX .. 69 . 8 6 11.7 10.0 . 54.5
F .. 71 . 10.0 10.3 7.7 . 42.4
AZ .. 79 8-0 11.7 8.6 . 52-5
AV .. 26 . 66 10.9 5- 7 . 43.8
AY . . 64 3-9 7.3 3.8 . 28.1
CP .. 79 . 46 6.9 5.9 . 314
CQ .. 64 . 27 9-3 11*4 . 38.5
CR .. 46 . 7.3 8.4 82 . 43-6
CZ .. 63 . 103 9.1 9.2 . 52.0
A histogram ofthe R.M.C.A. values ofthe patients studied in the present series
is shown in Fig. 2. In all except three patients the faecal radioactivity is in the
normal range suggesting that depression of the blood radioactivity curve is not
due to defective absorption of fat.
Although eight patients in the malignant series had an R.M.C.A. value in
the normal range statistical analysis of the difference between the mean of the
malignant group and of the normal group gave the significance detailed in Fig. 3.
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The malignant series was subdivided into (a) carcinomas and (b) other tumours
and reticuloses and an analysis similar to that above was carried out, the result
being shown in Fig. 4 and 5.
In 11 cases the test was carried out before and after the treatment. In 9 of
these regression of the tumour and clinical improvement had occurred at the
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FIG. 1.-Blood radioactivity, faecal radioactivity, and results of chemical fat balance studies in
a group of normal subjects.
time of the second test while in 2 cases the clinical condition had deteriorated.
The data referring to these tests are shown in Table II and the comparison of
the results is shown in Fig. 6.
We have not found any statistically evident influence on the R.M.C.A. values
of the age of the patients (over 64 years and under), the rate of tumour growth,
differentiation, or the tumour volume roughly calculated from clinical notes or
X-ray evaluations.
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FIG. 2. A histogram of the R.M.C.A. values and the faecal radioactivity obtained in a series of
normal patients and in a series with malignant disease.
TABLE II.-Experimental Data of Patients Tested
Before and After Treatment
Treatment
DXR-therapy
Mastectomy
DXR-therapy
60Co-therapy
6°Co-therapy
DXR-therapy
60Co-therapy
60Co-therapy
Chemotherapy
DXR-therapy
Chemotherapy
R.M.C.A.
r %
Before After
24-5 27-6
53.7 72-4
41-6 57.7
40 3 46-8
37-2 51-6
43-6 50- 7
45.4 78-8
50-6 81-2
48-6 46-8
29-8 23-5
39-2 26-4
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FIG. 3.-Histogram of the mean value of blood radioactivity of the control series (8 cases;
black columns) and the malignant series (34 cases; shaded columns). P and t have the
usual significance.
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FIG. 4.-A comparison of controls with carcinoma cases.
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FIG. 5.-Comparison of controls with a group of reticuloses, leukaemias and sarcomas,.
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FIG. 6.-Comparison of the mean R.M.C.A. value of patients tested before and after treatment.
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DISCUSSION
The technique used in this study is well known to be oflimited utility and the
results presented should be interpreted with caution. The significantly lower
mean values of blood radioactivity found in the malignant series compared with
that of the controls is apparently not due to a defect in absorption of fat. A
dynamic state is reflected by the curve of blood radioactivity: it represents the
balance between uptake of fat into the blood and its removal therefrom.
More rapid removal in malignant disease could merely be a secondary effect
of cachexia analagous to that found in starvation. It could also be caused by
preferential utilization by the tumour of freshly absorbed fat or by preferential
utilization of triolein either directly or by mobilization.
More elaborate biochemical methods than that used here are necessary to
throw further light on the problem but it appears to be well established that,
in some species of animals, tumours utilize the fatty acids of the host. Medes,
Thomas and Weinhouse (1953) calculated from the results of their experiments
that only about 5 per cent ofthe fat content oftumours could be accounted for by
endogenous synthesis. Haven (1940, 1941) has demonstrated the rapid turnover
of tumour lecithin, cephalin, and sphingomyelin.
It is tempting to suppose that this extensive utilization of the host fat by
tumours explains our findings, but a more simple explanation may be the correct
one. Further work is certainly called for.
SUMMARY
1. The well known 131I-triolein fat absorption test has been extended to study
the blood radioactivity levels in a series of 34 cases ofmalignant disease.
2. Following the ingestion of the labelled fat the bloodradioactivity wasfound
to be lower in the malignant series than it was in the control series.
3. Successful treatment moved the curve of blood radioactivity towards the
normal range while this effect did not occur in two cases where deterioration
continued after treatment.
4. Possible explanations for the results are discussed.
Since this paper was submitted for publication, Gore and Popjak (1961) state
"that tumour cells obtain theirlipids preformed from the host was experimentally
confirmed ".
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